Biofabrication of small diameter tissue-engineered vascular grafts

Volume: 138, Pages: 92 - 111
Published: Jan 1, 2022
Abstract
Current clinical treatment strategies for the bypassing of small diameter (<6 mm) blood vessels in the management of cardiovascular disease frequently fail due to a lack of suitable autologous grafts, as well as infection, thrombosis, and intimal hyperplasia associated with synthetic grafts. The rapid advancement of 3D printing and regenerative medicine technologies enabling the manufacture of biological, tissue-engineered vascular grafts...
Paper Details
Title
Biofabrication of small diameter tissue-engineered vascular grafts
Published Date
Jan 1, 2022
Volume
138
Pages
92 - 111
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.